162 related articles for article (PubMed ID: 34920376)
21. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
22. A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue.
Koo K; Harris R; Wiesenfeld D; Iseli TA
J Laryngol Otol; 2015 Jan; 129 Suppl 1():S27-31. PubMed ID: 25656280
[TBL] [Abstract][Full Text] [Related]
23. Implications of STAT signalling pathways and its associated molecules in the treatment of Oral Squamous Cell Carcinoma (OSCC).
Anees FF; Sekar D
J Stomatol Oral Maxillofac Surg; 2023 Jun; 124(3):101392. PubMed ID: 36681122
[No Abstract] [Full Text] [Related]
24. Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis.
Saluja TS; Ali M; Mishra P; Kumar V; Singh SK
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):144-153. PubMed ID: 30315141
[TBL] [Abstract][Full Text] [Related]
25. Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma.
Vijayashree Priyadharsini J; Abilasha R; Anitha P; Paramasivam A
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1):101277. PubMed ID: 36058533
[No Abstract] [Full Text] [Related]
26. Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma.
Li G; Da M; Zhang W; Wu H; Ye J; Chen J; Ma L; Gu N; Wu Y; Song X
J Oral Pathol Med; 2016 Mar; 45(3):167-72. PubMed ID: 26189546
[TBL] [Abstract][Full Text] [Related]
27. Glandular metaplasia in oral squamous cell carcinoma: Prognostic indicators? Deriving inference from urothelial and breast carcinoma.
Ramadoss R; Yuwanati M; Ramani P; Krishnan R; Annasamy R
Oral Oncol; 2022 Jan; 124():105639. PubMed ID: 34837728
[No Abstract] [Full Text] [Related]
28. Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinoma.
Nakashima T; Yasumatsu R; Masuda M; Clayman GL; Komune S
J Laryngol Otol; 2012 Nov; 126(11):1134-7. PubMed ID: 22963824
[TBL] [Abstract][Full Text] [Related]
29. Conspectus on nanodiagnostics as an incipient platform for detection of oral potentially malignant disorders and oral squamous cell carcinoma.
Shanmugam DK; Anitha SC; Najimudeen RA; Saravanan M; Arockiaraj J; Belete MA
Int J Surg; 2023 Mar; 109(3):542-544. PubMed ID: 36906784
[No Abstract] [Full Text] [Related]
30. The Great Imitator: Primary Syphilis Clinically Mimicking Oral Squamous Cell Carcinoma.
Magnaterra E; Grandi V; Pisano L
Am J Med; 2022 Sep; 135(9):1078-1079. PubMed ID: 35307358
[No Abstract] [Full Text] [Related]
31. Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy.
Poornachitra P; Muthukrishnan A; Devaraj E
Indian J Cancer; 2023 Oct; 60(4):595-596. PubMed ID: 38185867
[No Abstract] [Full Text] [Related]
32. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
[TBL] [Abstract][Full Text] [Related]
33. Leveraging artificial intelligence for perioperative cancer risk assessment of oral potentially malignant disorders.
Adeoye J; Su YX
Int J Surg; 2024 Mar; 110(3):1677-1686. PubMed ID: 38051932
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate.
Baik FM; Hansen S; Knoblaugh SE; Sahetya D; Mitchell RM; Xu C; Olson JM; Parrish-Novak J; Méndez E
JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):330-8. PubMed ID: 26892902
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of oral brush cytology cell block immunocytochemistry in the diagnosis of oral leukoplakia and oral squamous cell carcinoma.
Kujan O; Idrees M; Anand N; Soh B; Wong E; Farah CS
J Oral Pathol Med; 2021 May; 50(5):451-458. PubMed ID: 33368584
[TBL] [Abstract][Full Text] [Related]
36. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.
Scully C; Field JK; Tanzawa H
Oral Oncol; 2000 Sep; 36(5):404-13. PubMed ID: 10964046
[TBL] [Abstract][Full Text] [Related]
37. LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial.
McCaul JA; Cymerman JA; Hislop S; McConkey C; McMahon J; Mehanna H; Shaw R; Sutton DN; Dunn J
Trials; 2013 Sep; 14():310. PubMed ID: 24063578
[TBL] [Abstract][Full Text] [Related]
38. Lip and Oral Cavity Squamous Cell Carcinoma.
Howard A; Agrawal N; Gooi Z
Hematol Oncol Clin North Am; 2021 Oct; 35(5):895-911. PubMed ID: 34274176
[TBL] [Abstract][Full Text] [Related]
39. Comment on "Oral squamous cell carcinoma due to chronic mechanical irritation.".
Misra SR; Das R
Oral Oncol; 2022 Jan; 124():105661. PubMed ID: 34896893
[No Abstract] [Full Text] [Related]
40. Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
Li CX; Gong ZC; Tan XR
Cancer Immunol Immunother; 2023 Sep; 72(9):3133-3134. PubMed ID: 37149552
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
